Revelation Biosciences Stock Buy Hold or Sell Recommendation
| REVBW Stock | USD 0.01 0 16.50% |
Assuming the 90 days horizon and your highly speculative risk level, our recommendation regarding Revelation Biosciences is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Revelation Biosciences given historical horizon and risk tolerance towards Revelation Biosciences. When Macroaxis issues a 'buy' or 'sell' recommendation for Revelation Biosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Revelation Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide. Note, we conduct extensive research on individual companies such as Revelation and provide practical buy, sell, or hold advice based on investors' constraints. Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Revelation |
Execute Revelation Biosciences Buy or Sell Advice
The Revelation recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Revelation Biosciences. Macroaxis does not own or have any residual interests in Revelation Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Revelation Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Revelation Biosciences Trading Alerts and Improvement Suggestions
| Revelation Biosciences generated a negative expected return over the last 90 days | |
| Revelation Biosciences has high historical volatility and very poor performance | |
| Revelation Biosciences has some characteristics of a very speculative penny stock | |
| Revelation Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (120.25 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Revelation Biosciences has accumulated about 4.14 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.79, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Revelation Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Revelation Bio Achieves Key Manufacturing Milestone for Kidney Disease Drug Trial REVB Stock News - StockTitan |
Revelation Biosciences Returns Distribution Density
The distribution of Revelation Biosciences' historical returns is an attempt to chart the uncertainty of Revelation Biosciences' future price movements. The chart of the probability distribution of Revelation Biosciences daily returns describes the distribution of returns around its average expected value. We use Revelation Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Revelation Biosciences returns is essential to provide solid investment advice for Revelation Biosciences.
| Mean Return | 1.12 | Value At Risk | -20.86 | Potential Upside | 18.52 | Standard Deviation | 17.03 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Revelation Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Revelation Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Revelation Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Revelation Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Revelation stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.24 | |
β | Beta against Dow Jones | -1.58 | |
σ | Overall volatility | 9.71 | |
Ir | Information ratio | 0.06 |
Revelation Biosciences Volatility Alert
Revelation Biosciences is showing large volatility of returns over the selected time horizon. Revelation Biosciences is a penny stock. Although Revelation Biosciences may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Revelation Biosciences. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Revelation instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Revelation Biosciences Fundamentals Vs Peers
Comparing Revelation Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Revelation Biosciences' direct or indirect competition across all of the common fundamentals between Revelation Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Revelation Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Revelation Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Revelation Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Revelation Biosciences to competition |
| Fundamentals | Revelation Biosciences | Peer Average |
| Return On Equity | -2.7 | -0.31 |
| Return On Asset | -0.51 | -0.14 |
| Number Of Shares Shorted | 17.31 K | 4.71 M |
| EBITDA | (95.21 K) | 3.9 B |
| Net Income | (120.25 K) | 570.98 M |
| Cash And Equivalents | 4.14 M | 2.7 B |
| Cash Per Share | 1.79 X | 5.01 X |
| Total Debt | 5.56 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 2.58 X | 2.16 X |
| Book Value Per Share | 0.62 X | 1.93 K |
| Cash Flow From Operations | (7.29 M) | 971.22 M |
| Earnings Per Share | (4.77) X | 3.12 X |
| Number Of Employees | 9 | 18.84 K |
| Beta | 0.15 | -0.15 |
| Total Asset | 12.21 M | 29.47 B |
| Retained Earnings | (25.47 M) | 9.33 B |
| Working Capital | 6.58 M | 1.48 B |
| Net Asset | 12.21 M |
Revelation Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Revelation . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Revelation Biosciences Buy or Sell Advice
When is the right time to buy or sell Revelation Biosciences? Buying financial instruments such as Revelation Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Revelation Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Funds Thematic Idea Now
Consumer Funds
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.